Abbott Laboratories Share Price Buenos Aires S.E.
Stocks
ABT
ARDEUT110608
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Buenos Aires S.E.
11/09/2026
|
5-day change | 1st Jan Change | ||
| 40,980.00 ARS | -0.87% |
|
-4.56% | -14.23% |
| 08/09 | Abbott Receives FDA Approval for Device to Treat Abnormal Heart Rhythm | DJ |
| 08/09 | Abbott Receives FDA Approval for TactiFlex Duo Ablation Catheter to Treat Abnormal Heart Rhythms | CI |
| Market Cap | 18TCr 2,66,64800Cr 15TCr 14TCr 13TCr 24TCr 16,85400Cr 25TCr 1,70900Cr 66TCr 8,57400Cr 66TCr 65TCr 27,09400Cr | P/E 2026 * |
28.9x | P/E 2027 * | 22.4x |
|---|---|---|---|---|---|
| Enterprise Value | 20TCr 3,02,83100Cr 17TCr 16TCr 15TCr 28TCr 19,14100Cr 28TCr 1,94100Cr 75TCr 9,73800Cr 75TCr 74TCr 30,77100Cr | EV / Sales 2026 * |
3.99x | EV / Sales 2027 * | 3.62x |
| Free-Float |
86.16% | Yield 2026 * |
2.52% | Yield 2027 * | 2.69% |
| Markets | Quality | ||
|---|---|---|---|
Buenos Aires S.E.
| ABT | End-of-day quote | |
Buenos Aires S.E.
| ABTD | End-of-day quote |
Last Transcript : Abbott Laboratories
| 1 day | -0.87% | ||
| 1 week | -4.56% | ||
| Current month | -6.99% | ||
| 1 month | -6.74% | ||
| 3 months | +24.48% | ||
| 6 months | +3.80% | ||
| Current year | -14.23% |
| 1 week | 40,520 |  | 43,920 |
| 1 month | 40,520 | | 46,940 |
| Current year | 30,380 | | 49,620 |
| 1 year | 30,380 | | 53,525 |
| 3 years | 18,337 | | 53,525 |
| 5 years | 5,360.5 | | 53,525 |
| 10 years | 145 | | 53,525 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 31/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 01/09/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 09/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 09/12/2011 |
Daniel Starks
BRD | Director/Board Member | 71 | 16/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.87% | -4.56% | - | - | 18TCr | |
| -1.36% | -5.89% | -23.76% | -0.44% | 18TCr | |
| -0.72% | -3.41% | -3.26% | +12.32% | 12TCr | |
| +0.19% | -2.83% | +6.30% | +80.17% | 6.14TCr | |
| -1.92% | -6.01% | +7.05% | +38.44% | 4.94TCr | |
| +0.81% | -3.73% | -4.81% | -32.56% | 4.84TCr | |
| -1.75% | -5.54% | +8.93% | -20.82% | 3.13TCr | |
| +0.43% | -11.10% | - | - | 2.85TCr | |
| +0.58% | +1.84% | +36.58% | -12.08% | 2.44TCr | |
| +0.49% | -7.65% | -13.30% | +3.79% | 2.16TCr | |
| Average | -0.41% | -5.08% | +1.72% | +8.60% | 6.2TCr | |
| Weighted average by Cap. | -0.73% | -4.90% | -6.02% | +10.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.02TCr 75,88400Cr 4.33TCr 4.1TCr 3.71TCr 6.96TCr 4,79600Cr 7TCr 49TCr 19TCr 2,44000Cr 19TCr 18TCr 7,71100Cr | 5.45TCr 82,41900Cr 4.7TCr 4.45TCr 4.03TCr 7.56TCr 5,20900Cr 7.6TCr 53TCr 20TCr 2,65000Cr 20TCr 20TCr 8,37500Cr |
| Net income | 630.32Cr 9,52700Cr 543.08Cr 514.22Cr 466.09Cr 874.42Cr 60TCr 878.85Cr 6.11TCr 2.35TCr 31TCr 2.37TCr 2.32TCr 97TCr | 797.76Cr 12,05800Cr 687.35Cr 650.83Cr 589.91Cr 1.11TCr 76TCr 1.11TCr 7.73TCr 2.97TCr 39TCr 3TCr 2.93TCr 1,22500Cr |
| Net Debt | 2.39TCr 36,18400Cr 2.06TCr 1.95TCr 1.77TCr 3.32TCr 2,28700Cr 3.34TCr 23TCr 8.92TCr 1,16400Cr 8.99TCr 8.79TCr 3,67700Cr | 2.1TCr 31,67700Cr 1.81TCr 1.71TCr 1.55TCr 2.91TCr 2,00200Cr 2.92TCr 20TCr 7.81TCr 1,01900Cr 7.87TCr 7.7TCr 3,21900Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/26/11 | ARS 40,980.00 | -0.87% | 998 |
| 10/26/10 | ARS 41,340.00 | -1.43% | 993 |
| 09/26/09 | ARS 41,940.00 | -0.29% | 1,273 |
| 08/26/08 | ARS 42,060.00 | -1.73% | 1,913 |
| 07/26/07 | ARS 42,800.00 | -0.33% | 252 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
- ABT Stock
Select your edition
All financial news and data tailored to specific country editions
